13F Pro

SEC Form 4 reporting owner

Afeyan Noubar

Afeyan Noubar has filed 17 Form 4 transactions reported between December 11, 2025 and May 21, 2026, as Director of Moderna, Inc. and a reporting owner of Generate Biomedicines, Inc..

Name as filed: AFEYAN NOUBAR

Open-market buys, 24 mo
$25.0M
1 lines
Open-market sales, 24 mo
None
reported
Companies
2
with Form 4 filings
Latest transaction
May 21, 2026
transaction date

Roles and reported holdings

  • MRNAModerna, Inc.
    Dec 11, 2025 – May 21, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • GENBGenerate Biomedicines, Inc.
    Feb 26, 2026 – Mar 2, 2026

    Reporting owner

    Held indirectly (latest line)15,264,724 sh as of Mar 2, 2026 · Form 4

    24 months: $25.0M bought

Transaction history

All 17 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
May 21, 2026MRNAOption exerciseCode M · indirect9,263$177K@ $19.15Form 4
May 6, 2026MRNADirectorGrant or awardCode A · direct12,908—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect2,531,644—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect2,109,704—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect2,953,586—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect1,265,822—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect843,881—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect1,500,000—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect17,016,215—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect18,483,785—Form 4
Mar 2, 2026GENBOpen-market purchaseCode P · indirect1,562,500$25.0M@ $16.00Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect2,777,752—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect987,491—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect13,702,224—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect12,723,940—Form 4
Feb 26, 2026GENBGrant or awardCode A · direct29,561—Form 4
Dec 11, 2025MRNAOption exerciseCode M · indirect23,853$260K@ $10.90Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.